Cell Biotech Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Cell Biotech.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth	43.7%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Factors Income Investors Should Consider Before Adding Cell Biotech Co., Ltd. (KOSDAQ:049960) To Their Portfolio

May 05

Is Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Recent Price Movement Underpinned By Its Weak Fundamentals?

Mar 18

A Look At Cell Biotech's (KOSDAQ:049960) Share Price Returns

Feb 25

Key Things To Watch Out For If You Are After Cell Biotech Co., Ltd.'s (KOSDAQ:049960) 3.2% Dividend

Feb 04

Is Cell Biotech Co., Ltd. (KOSDAQ:049960) Popular Amongst Insiders?

Jan 14

Don't Race Out To Buy Cell Biotech Co., Ltd. (KOSDAQ:049960) Just Because It's Going Ex-Dividend

Dec 24

Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Dec 13

Reflecting on Cell Biotech's (KOSDAQ:049960) Share Price Returns Over The Last Five Years

Nov 18

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cell Biotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A049960 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2023	53,787	6,304	6,140	7,815	N/A
9/30/2023	52,751	166	3,073	5,128	N/A
6/30/2023	51,509	2,736	6,352	9,333	N/A
3/31/2023	51,272	8,128	3,758	6,816	N/A
12/31/2022	50,526	8,281	10,141	12,814	N/A
9/30/2022	48,754	14,642	11,538	13,660	N/A
6/30/2022	49,081	12,997	11,838	13,137	N/A
3/31/2022	48,328	10,632	17,779	18,913	N/A
12/31/2021	46,873	10,383	14,070	14,892	N/A
9/30/2021	45,761	6,032	6,702	7,815	N/A
6/30/2021	44,196	3,270	7,710	9,220	N/A
3/31/2021	44,156	2,942	7,328	9,763	N/A
12/31/2020	45,582	3,189	6,471	9,564	N/A
9/30/2020	46,990	5,900	5,861	9,984	N/A
6/30/2020	46,333	6,472	-1,147	4,866	N/A
3/31/2020	46,582	8,017	-5,305	3,626	N/A
12/31/2019	45,960	7,231	522	10,231	N/A
9/30/2019	49,346	11,379	2,626	14,714	N/A
6/30/2019	53,473	13,585	6,252	16,896	N/A
3/31/2019	58,136	16,544	9,031	17,346	N/A
12/31/2018	62,544	19,384	6,600	13,976	N/A
9/30/2018	60,324	16,525	17,987	23,491	N/A
6/30/2018	61,301	17,865	17,065	20,963	N/A
3/31/2018	62,295	19,802	18,100	24,204	N/A
12/31/2017	61,057	18,198	16,984	22,528	N/A
9/30/2017	62,706	20,756	N/A	15,812	N/A
6/30/2017	58,937	18,581	N/A	19,302	N/A
3/31/2017	57,150	17,071	N/A	15,987	N/A
12/31/2016	58,276	18,499	N/A	17,991	N/A
9/30/2016	55,048	17,719	N/A	21,522	N/A
6/30/2016	57,418	21,705	N/A	25,873	N/A
3/31/2016	55,230	20,603	N/A	21,743	N/A
12/31/2015	49,505	17,505	N/A	18,236	N/A
9/30/2015	49,291	16,582	N/A	13,263	N/A
6/30/2015	44,997	12,474	N/A	5,812	N/A
3/31/2015	41,350	10,329	N/A	10,455	N/A
12/31/2014	40,768	10,403	N/A	9,907	N/A
9/30/2014	39,111	9,929	N/A	10,426	N/A
6/30/2014	36,560	8,879	N/A	10,150	N/A
3/31/2014	34,823	8,998	N/A	10,344	N/A
12/31/2013	31,598	7,800	N/A	8,988	N/A
9/30/2013	27,687	6,604	N/A	7,556	N/A
6/30/2013	27,269	5,976	N/A	5,934	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A049960's forecast earnings growth is above the savings rate (2.5%).

Earnings vs Market: Insufficient data to determine if A049960's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A049960's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A049960's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A049960's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A049960's Return on Equity is forecast to be high in 3 years time

Cell Biotech Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Full year 2023 earnings released: EPS: ₩921 (vs ₩1,201 in FY 2022)

Now 21% overvalued after recent price rise

Now 23% overvalued after recent price rise

Now 21% overvalued after recent price rise

Upcoming dividend of ₩450 per share at 4.0% yield

New minor risk - Earnings quality

First quarter 2023 earnings released: EPS: ₩417 (vs ₩434 in 1Q 2022)

Now 20% undervalued

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: ₩1,201 (vs ₩1,468 in FY 2021)

Upcoming dividend of ₩450 per share

No independent directors

Investor sentiment deteriorated over the past week

No independent directors

Upcoming dividend of ₩450 per share

Factors Income Investors Should Consider Before Adding Cell Biotech Co., Ltd. (KOSDAQ:049960) To Their Portfolio

Is Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At Cell Biotech's (KOSDAQ:049960) Share Price Returns

New 90-day low: ₩18,300

Key Things To Watch Out For If You Are After Cell Biotech Co., Ltd.'s (KOSDAQ:049960) 3.2% Dividend

Is Cell Biotech Co., Ltd. (KOSDAQ:049960) Popular Amongst Insiders?

Don't Race Out To Buy Cell Biotech Co., Ltd. (KOSDAQ:049960) Just Because It's Going Ex-Dividend

New 90-day high: ₩21,850

Upcoming Dividend of ₩600 Per Share

Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

New 90-day high: ₩20,500

Reflecting on Cell Biotech's (KOSDAQ:049960) Share Price Returns Over The Last Five Years

New 90-day high: ₩17,600

Cell Biotech Co., Ltd.(KOSDAQ:A049960) dropped from S&P Global BMI Index

New 90-day low - ₩15,350

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies